This Beaten-Down Artificial Intelligence (AI) Stock Just Got Some Great News: Time to Buy?

Artificial intelligence (AI) is taking over the world. The U.S. Food and Drug Administration (FDA) recently announced it would phase out animal testing in drug development in favor of other methods, including AI-based testing. Recursion Pharmaceuticals built the largest AI supercomputer in the pharmaceutical industry with the help of tech giant Nvidia.